Biotechnology BioMarin Announces Favorable Results from Global Phase 2 Study of VOXZOGO(TM) (vosoritide) for Injection in Infants and Young Children with Achondroplasia at The Endocrine Society Annual Meeting, ENDO 2022 (June 11-14), in Atlanta June 13, 2022
Biotechnology SHAREHOLDER ALERT: AUPH IRNT AXSM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines June 13, 2022
Biotechnology INVESTIGATION NOTICE: The Schall Law Firm Announces Investigation of Breaches of Fiduciary Duties by Management of Allakos Inc.- ALLK June 13, 2022
Biotechnology New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unseen Burden and Care Challenges of Sickle Cell Disease June 13, 2022
Biotechnology BridgeBio Pharma Shares Positive Phase 2b Data and Announces Pivotal Study Design for Phase 3 Trial of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) June 13, 2022
Biotechnology Biohaven Presents New Migraine Data at 64th Annual Scientific Meeting of the American Headache Society, including First of Its Kind Study for Nurtec® ODT (rimegepant), and Complete Phase 3 Data for Zavegepant Nasal Spray June 13, 2022
Search
Biotechnology
